Conformis Launches Cordera Match Hip in the U.S.

Conformis launched the Cordera™ Match Hip System in the U.S. Cleared for marketing by FDA earlier this year, Cordera Match represents one of multiple planned product extensions featuring the Cordera Hip System.

Cordera Match Hip is an uncemented, primary total hip replacement composed of femoral and acetabular components. It is implanted using the iView® personalized surgical plan and iJig® patient-specific instrumentation. The procedure can be performed with just one reusable instrument tray. The implants and instruments are delivered sterile to hospitals and ambulatory surgery centers.

“Our new Cordera™ Match Hip System begins the expansion of our growing total hip portfolio. The system, which is inserted using either an anterior or posterior surgical approach, is designed to allow more surgeons to treat a wider range of hip patients effectively,” said Mark Augusti, President and CEO. “Over the next year, we plan to launch multiple product extensions featuring the Cordera™ stem. With this first offering, surgeons who like to operate with the Cordera™ stem will benefit from the significant value provided by Conformis’ personalized surgical plan and best-in-class PSI guides, all delivered through a safe, sterile, and efficient model for hospitals and ASC sites of care.”